Skip to content
StockMarketAgent
Healthcare / Medical DistributionUpdated 2026-05-10 22:07 UTC

ASX/EBO stock hub

ASX/EBO has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ASX/EBOis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
3.6B
Australian Securities Exchange
Market data

Live price

Current market quote for this ticker.

Current price
ASX/EBO
In the news

Latest news · ASX/EBO

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E14
P25 12.9P50 20.4P75 41.2
Trailing P/E15.9
P25 14.2P50 19.2P75 35.1
ROE9
P25 -118.7P50 -49.4P75 -1.2
ROIC7.1
P25 -74.7P50 -33.5P75 0.1
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ASX/EBO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
235
Groups with data
11
Currency
AUD
Showing 235 of 235 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
New Zealand
Country code
AU
Employees
5,800
Employees Change
807%
Employees Change Percent
16.26
Enterprise value
AUD 5.1B
Exchange
Australian Securities Exchange
Financial currency
AUD
First seen
2026-05-10
Industry
Medical Distribution
Isin
NZEBOE0001S6
Last refreshed
2026-05-10
Market cap
AUD 3.6B
Price
AUD 17.49
Price currency
AUD
Rev Per Employee
2,248,826.9x
Sector
Healthcare
Sic
5047
Symbol
asx/EBO
Website
https://www.ebosgroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
6.3%
EV Earnings
22.25x
EV/EBIT
12.61x
EV/EBITDA
9.15x
EV/FCF
35.66x
EV/Sales
0.41x
FCF yield
3.93%
Forward P/E
14.03x
P/B ratio
1.35x
P/E ratio
15.87x
P/S ratio
0.28x
PE Ratio10 Y
28.06x
PE Ratio3 Y
26.66x
PE Ratio5 Y
25.23x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

27
MetricValue
EBIT Margin
3.15%
EBITDA Margin
3.82%
FCF margin
1.1%
Gross margin
13.08%
Gross Profit
AUD 1.7B
Gross Profit Growth
4.2%
Gross Profit Growth Q
8.61%
Gross Profit Growth3 Y
1.47%
Gross Profit Growth5 Y
1.97%
Net Income
AUD 229.5M
Net Income Growth
-6.67%
Net Income Growth Q
12.97%
Net Income Growth Quarters
1%
Net Income Growth Years
0%
Net Income Growth3 Y
-5.46%
Net Income Growth5 Y
-1.96%
Pretax Margin
2.37%
Profit Margin
1.76%
Profit Per Employee
AUD 39,563
Profitable Years
22
ROA
3.56
Roa5y
4.31
ROCE
8.42
ROE
8.97
Roe5y
11.34
ROIC
7.14
Roic5y
9.26

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

27
MetricValue
Cagr10y
5.26%
Cagr1y
-47.78%
Cagr3y
-21.97%
Cagr5y
-6.31%
Div CAGR10
8.34%
Div CAGR3
3.5%
Div CAGR5
6.11%
EPS Growth
-11.14
EPS Growth Q
6.68
EPS Growth Quarters
1
EPS Growth Years
0
EPS Growth3 Y
-7.18
EPS Growth5 Y
-3.2
FCF Growth
-58.54%
FCF Growth3 Y
-17.22%
FCF Growth5 Y
-13.6%
OCF Growth
-36.38%
OCF Growth Q
-75.47%
OCF Growth10 Y
0.82%
OCF Growth3 Y
-7.54%
OCF Growth5 Y
-6.8%
Revenue Growth
3.53x
Revenue Growth Q
12.96x
Revenue Growth Quarters
2x
Revenue Growth Years
0x
Revenue Growth3 Y
-0.37x
Revenue Growth5 Y
1.28x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
AUD 1.81
Assets
AUD 7.6B
Cash
AUD 261.2M
Current Assets
AUD 3.4B
Current Liabilities
AUD 2.7B
Debt
AUD 1.8B
Debt EBITDA
AUD 3.23
Debt Equity
AUD 0.68
Debt FCF
AUD 12.89
Equity
AUD 2.7B
Interest Coverage
3.45
Liabilities
AUD 4.9B
Long Term Assets
AUD 4.2B
Long Term Liabilities
AUD 2.2B
Net Cash
AUD -1.6B
Net Cash By Market Cap
AUD -43.51
Net Debt EBITDA
AUD 3.18
Net Debt Equity
AUD 0.59
Net Debt FCF
AUD 11.07
Tangible Book Value
AUD -143.2M
Tangible Book Value Per Share
AUD -0.7
WACC
5.16

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.24
Inventory Turnover
8.74
Net Working Capital
AUD 490.9M
Quick ratio
0.72
Working Capital
AUD 645.5M
Working Capital Turnover
AUD 22.26

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

10
MetricValue
Buyback Yield
-5.07%
Dividend Growth
-4.67%
Dividend Growth Years
0%
Dividend per share
AUD 1.08
Dividend Years
13
Dividend Yield
6.15%
Ex Div Date
2026-03-05
Last Dividend
AUD 0.5
Payout Frequency
Semi-Annual
Payout Ratio
57.45%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

36
MetricValue
10Y total return
66.98%
1Y total return
-47.76%
200-day SMA
24.37
3Y total return
-52.5%
50-day SMA
18.41
50-day SMA vs 200-day SMA
50under200
5Y total return
-27.82%
All Time High
45.77
All Time High Change
-61.79%
All Time High Date
2023-01-17
All Time Low
8
All Time Low Change
118.63%
All Time Low Date
2014-10-17
ATR
0.51
Beta
0.2
Ch YTD
-26.02
High
18.03
High52
38.23
High52 Date
2025-08-21
High52ch
-54.25%
Low
17.47
Low52
17.06
Low52 Date
2026-04-29
Low52ch
2.52%
Ma50ch
-4.98%
Price vs 200-day SMA
-28.23%
RSI
42.15
RSI Monthly
23.87
RSI Weekly
21.11
Sharpe ratio
-2.39x
Sortino ratio
-2.65
Total Return
1.08%
Tr YTD
-24.1
Tr1m
-7.75%
Tr1w
0.4%
Tr3m
-16.2%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
AUD 410.5M
Operating Income Growth
-3.15
Operating Income Growth Q
-6.69
Operating Income Growth3 Y
-5.29
Operating Income Growth5 Y
-1.61
Operating margin
3.15

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

6
MetricValue
Float
196,629,000%
Net Borrowing
8,489,000
Shares Insiders
0.17%
Shares Institutions
32.09%
Shares Qo Q
2.48%
Shares Yo Y
5.07%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

61
MetricValue
Adjusted FCF
AUD 146M
Average Volume
129,499.15x
Bv Per Share
13.42
CAPEX
AUD -132.1M
Ch10y
18.98
Ch1m
-7.75
Ch1w
0.4
Ch1y
-50.09
Ch3m
-18.31
Ch3y
-57.52
Ch5y
-38.74
Ch6m
-29.5
Change
-1.91%
Change From Open
-0.85
Close
17.83
Days Gap
-1.07
Depreciation Amortization
87,182,000
Dollar Volume
3,370,620.3
Earnings Date
2026-05-25
EBIT
AUD 410.5M
EBITDA
AUD 497.7M
EPS
AUD 1.13
F Score
6
FCF
AUD 143.1M
FCF EV Yield
2.8x
Financing CF
129,180,000
Fiscal Year End
June
Founded
1,922
Goodwill
2,277,619,000
Graham Number
17.94765
Graham Upside
2.62
Income Tax
AUD 78.5M
Investing CF
-388,742,000
Is Primary Listing
0
Last Earnings Date
2026-02-25
Last Report Date
2025-12-31
Lynch Fair Value
AUD 5.51
Lynch Upside
-68.49
Ma150
21.97
Ma150ch
-20.4%
Ma20
17.77
Ma20ch
-1.58%
Net CF
12,373,000
Next Earnings Date
2026-05-25
Open
17.64
P FCF Ratio
25.43
P OCF Ratio
13.23
Payment Date
2026-03-27
Position In Range
3.57
Ppne
992,954,000
Price Date
2026-05-08
Price EBITDA
AUD 7.31
Relative Volume
1.52x
Revenue
13,043,196,000x
SBC By Revenue
-0.02x
Share Based Comp
-2,889,000
Tax By Revenue
0.6x
Tax Rate
25.4%
Tr6m
-27.68%
Volume
192,717
Z Score
2.88
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

ASX/EBO dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield
+6.2%
$1.08 annual per share
Payout ratio
+57.5%
Share of earnings returned as dividends. Below 60% is generally sustainable.
5Y dividend CAGR
+6.1%
0 consecutive years of growth
Total shareholder yield
+1.1%
Next ex-dividend date: 2026-03-05
Performance

ASX/EBO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-47.8%
S&P 500 1Y: n/a
3Y total return
-52.5%
S&P 500 3Y: n/a
5Y total return
-27.8%
S&P 500 5Y: n/a
10Y total return
+67.0%
S&P 500 10Y: n/a
Ownership

Who owns ASX/EBO?

Insider, institutional, and short-interest positioning.

Institutional ownership
+32.1%
Share of float held by funds and institutions
Insider ownership
+0.2%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
Float sold short by bearish positioning
Y/Y dilution
+5.1%
Negative means the company is buying back shares.
Technical

ASX/EBO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
42.2
Neutral momentum band
Price vs 200-day MA
-28.2%
50/200-day relationship not available
Beta (5Y)
0.20
Less volatile than the market
Sharpe ratio
-2.39
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ASX/EBO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/EBO stock rating?

asx/EBO is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/EBO analysis?

The full report lives at /stocks/asx/EBO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/EBO?

The latest report frames asx/EBO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/EBO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

asx/EBO stock profile: metrics, valuation and analysis | StockMarketAgent.AI